# Evaluation of the Effectiveness, Safety, and Tolerability of Duac Akne Gel and Epiduo Gel in the Treatment of Facial Acne Vulgaris

> **NCT00757523** · PHASE4 · COMPLETED · sponsor: **Stiefel, a GSK Company** · enrollment: 382 (actual)

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** Epiduo Gel
- **DRUG:** Duac Gel

## Key facts

- **NCT ID:** NCT00757523
- **Lead sponsor:** Stiefel, a GSK Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09-10
- **Primary completion:** 2009-04-24
- **Final completion:** 2009-06-24
- **Target enrollment:** 382 (ACTUAL)
- **Last updated:** 2017-08-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00757523

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00757523, "Evaluation of the Effectiveness, Safety, and Tolerability of Duac Akne Gel and Epiduo Gel in the Treatment of Facial Acne Vulgaris". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT00757523. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*